Dergiler / Turkish Journal of Pediatrics / 2016 / Cilt: 58 - Sayı: 5

A new emerging problem in pediatric emergency units: Synthetic cannabinoids

Sayfa
492–497
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Physicians in emergency departments should be educated on this issue and it must be kept in mind that most of the patients admitted are with complaints related to changes in the cognitive state (of consciousness) but they can also apply with complaints about all other systems.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aladağ-Çiftdemir N, Yücel İ, Duran R, Vatansever-Özbek Ü, Acunaş B.
📊
Temel Bulgular & Veri:Turk J Pediatr 2016; 58: 492-497.Synthetic cannabinoids or synthetic marijuana derivatives known as "Bonzai" in Turkey are addictive substances that affect the brain and have serious side effects.
💡
Sonuç & Katkı:Physicians in emergency departments should be educated on this issue and it must be kept in mind that most of the patients admitted are with complaints related to changes in the cognitive state (of consciousness) but they can also apply with complaints about all other systems.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Aladağ-Çiftdemir N, Yücel İ, Duran R, Vatansever-Özbek Ü, Acunaş B. A new emerging problem in pediatric emergency units: Synthetic cannabinoids. Turk J Pediatr 2016; 58: 492-497.Synthetic cannabinoids or synthetic marijuana derivatives known as "Bonzai" in Turkey are addictive substances that affect the brain and have serious side effects. In recent years, the use of these substances has also been increasing in our country as well as all over the world. These substances present with various names and brands, the most common names in Turkey are "Bonzai" and "Jamaika". In this study, we aimed to evaluate the demographic and clinical findings of these patients. We retrospectively evaluated patients admitted to our pediatric emergency department between March 2013 and March 2015 due to the complaints developing after the use of "Bonzai" in terms of age, gender, admission date, complaint, clinical findings, laboratory findings, consuming method of the substance, additional substance use, observation durations, hospitalization status and mortality rates. The most common complaint was faintness and drowsiness. Changes in the state of consciousness, tachycardia, hypertension were the most common clinical findings. Most common consuming method of the drug was in the form of smoking. The rate of "Bonzai" use among adolescents is increasing every day. Physicians in emergency departments should be educated on this issue and it must be kept in mind that most of the patients admitted are with complaints related to changes in the cognitive state (of consciousness) but they can also apply with complaints about all other systems.

🔖

Bu Makaleye Atıf Yap

ÇİFTDEMİR, N. A., YÜCEL, İ., DURAN, R., VATANSEVER-ÖZBEK, Ü., ACUNAŞ, B. (2016). A new emerging problem in pediatric emergency units: Synthetic cannabinoids. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 5, 492–497. https://ajindex.com/articles/412247

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Artuç S, Doğan KH, Demirci Ş. Uyuşturucu maddelerde yeni trend: Sentetik Kannabinoidler. Adli Tıp Bülteni 2014; 19: 198-203
  2. Ergül DF, Ekemen S, Büyükkıdan Yelken B. Sentetik kannabinoid 'Bonzai' intoksikasyonu: Altı olgu serisi. Türk Anestezi ve Reanimasyon Dergisi 2015; 43: 347- 351
  3. Kalyoncu ÖA, Ünlü B, Taştan U. Gençlerin tehlikeli oyunu: Sentetik kannabinoidler (Bonzai) üzerine bir gözden geçirme. Bağımlılık Dergisi 2014; 15: 150-155
  4. Gurdal F, Asirdizer M, Aker RG, et al. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. J Forensic Leg Med 2013; 20: 667-672
  5. Rella JG. Recreational cannabis use: Pleasures and pitfalls. Cleveland Clin J Med 2015; 82: 765-772. 6. http://www.emcdda.europa.eu/attachements.cfm/ att_212361_EN_EMCDDA_POD_2013_ Synthetic%20 cannabinoids.pdf. (Accessed: February 10, 2016)
  6. Besli GE, Ikiz MA, Yildirim S, et al. Synthetic Cannabinoid Abuse in Adolescents: A Case Series. J Emerg Med 2015; 49: 644-650
  7. Bozkurt M, Umut G, Evren C, et al. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları. Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi 2014; 27: 328-334
  8. Hudson S.,Ramsey J, King L, et al. Use of highresolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products, J Anal Toxicol 2010; 34: 252-260
  9. Küçük E, Küçük İ, Kirazaldı YY. Acil serviste yeni bir tehlike: Sentetik kannabinoidler (Bonzai, Jameika). Genel Tıp Dergisi 2015; 25: 18-22
  10. Seely KA, Patton AL, Moran CL, et al. Forensic investigation of K2, Spice, and ''bath salt'' commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Sci Int 2013; 233: 416-422
  11. Harris CR, Brown A. Synthetic cannabinoid intoxication: a case series and review. J Emerg Med 2013; 44: 360- 336
  12. Thornton SL, Akpunonu P, Glauner K, et al. Unintentional pediatric exposure to synthetic cannabinoid (AB-PINACA) resulting in coma and intubation. Ann Emerg Med 2015; 66: 343-344
  13. Lavi E, Rekhtman D, Berkun Y, et al. Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication. Eur J Pediatr 2016; 175: 417- 420
  14. Forrester MB. Adolescent synthetic cannabinoid exposures reported to Texas poison c